An In Vitro Model of Gastric Inflammation and Treatment with Cobalamin
Pernicious anaemia (PA) is an autoimmune condition where antibodies target intrinsic factor and parietal cells, reducing the patient's ability to absorb cobalamin promoting atrophic gastritis. Treatment guidelines are based on excretion data of hydroxocobalamin from healthy individuals obtained...
Saved in:
Main Authors: | T. R. Elliott (Author), A. L. Guildford (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of cellular cobalamin metabolism in Gaucher disease
by: Suelen Porto Basgalupp, et al.
Published: (2020) -
Decreased cobalamin sensitivity and biological aging acceleration in the general population
by: Fan Tang, et al.
Published: (2024) -
Vitamin B12 (cobalamin) deficiency in gastroenterological diseases - review
by: Piotr Zatyka, et al.
Published: (2024) -
Role of Folate, Cobalamin, and Probiotics in COVID-19 Disease Management [Letter]
by: Asad D, et al.
Published: (2021) -
Effect of Administration Route on the Pharmacokinetics of Cobalamin in Elderly Patients: A Randomized Controlled Trial
by: Monique P.H. Tillemans, PharmD, et al.
Published: (2014)